Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Jul 30;53(47):12930–12935. doi: 10.1002/anie.201403936

Figure 3.

Figure 3

Inhibitory effects of L2 and erlotinib on EGFR signaling. A431 cells were grown in medium with (+) or without (−) FCS and treated with the indicated drug for 4 h. After EGFR stimulation with 50 ng mL −1 EGF for 15 min, cells were harvested and lysed, and the activation of EGFR downstream pathways (pERK, pEGFR) was analyzed by Western blotting.